Currency: CNY
Period
Q1 FY2024 Earnings
--
215.70M
0.46
Strong Buy
Jul 2, 2024
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Baicheng Pharmaceutical: Report for the first quarter of 2024
Apr 22 12:00 ET
Baicheng Pharmaceutical: 2023 Annual Report
Baicheng Pharmaceutical: 2023 Annual Report Summary
Baicheng Pharmaceutical: Report for the third quarter of 2023
Oct 25, 2023 12:00 ET
Read more
Updated: Jul 2, 2024
Buy
Hold
Underperform
Sell
No Data